134 related articles for article (PubMed ID: 38743236)
1. Generation of Anti-HIV CAR-T Cells for Preclinical Research.
Su H; Anthony-Gonda K; Orentas RJ; Dropulić B; Goldstein H
Methods Mol Biol; 2024; 2807():287-298. PubMed ID: 38743236
[TBL] [Abstract][Full Text] [Related]
2. In Vivo Generation of CAR T Cells Selectively in Human CD4
Agarwal S; Hanauer JDS; Frank AM; Riechert V; Thalheimer FB; Buchholz CJ
Mol Ther; 2020 Aug; 28(8):1783-1794. PubMed ID: 32485137
[TBL] [Abstract][Full Text] [Related]
3. HIV-1-Specific Chimeric Antigen Receptor T Cells Fail To Recognize and Eliminate the Follicular Dendritic Cell HIV Reservoir
Ollerton MT; Berger EA; Connick E; Burton GF
J Virol; 2020 May; 94(10):. PubMed ID: 32161179
[TBL] [Abstract][Full Text] [Related]
4. Recent advances on anti-HIV chimeric antigen receptor-T-cell treatment to provide sustained HIV remission.
Su H; Mueller A; Goldstein H
Curr Opin HIV AIDS; 2024 Jul; 19(4):169-178. PubMed ID: 38695148
[TBL] [Abstract][Full Text] [Related]
5. CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIV.
Kim GB; Hege K; Riley JL
Front Immunol; 2019; 10():2310. PubMed ID: 31611880
[TBL] [Abstract][Full Text] [Related]
6. Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model.
Anthony-Gonda K; Bardhi A; Ray A; Flerin N; Li M; Chen W; Ochsenbauer C; Kappes JC; Krueger W; Worden A; Schneider D; Zhu Z; Orentas R; Dimitrov DS; Goldstein H; Dropulić B
Sci Transl Med; 2019 Aug; 11(504):. PubMed ID: 31391322
[TBL] [Abstract][Full Text] [Related]
7. Robust CAR-T memory formation and function via hematopoietic stem cell delivery.
Zhen A; Carrillo MA; Mu W; Rezek V; Martin H; Hamid P; Chen ISY; Yang OO; Zack JA; Kitchen SG
PLoS Pathog; 2021 Apr; 17(4):e1009404. PubMed ID: 33793675
[TBL] [Abstract][Full Text] [Related]
8. CD20 CAR T cells safely and reversibly ablate B cell follicles in a non-human primate model of HIV persistence.
Bui JK; Starke CE; Poole NH; Rust BJ; Jerome KR; Kiem HP; Peterson CW
Mol Ther; 2024 May; 32(5):1238-1251. PubMed ID: 38414244
[TBL] [Abstract][Full Text] [Related]
9. Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity.
Ghanem MH; Bolivar-Wagers S; Dey B; Hajduczki A; Vargas-Inchaustegui DA; Danielson DT; Bundoc V; Liu L; Berger EA
Cytotherapy; 2018 Mar; 20(3):407-419. PubMed ID: 29306566
[TBL] [Abstract][Full Text] [Related]
10. Development of CAR-T cells for long-term eradication and surveillance of HIV-1 reservoir.
Liu B; Zhang W; Zhang H
Curr Opin Virol; 2019 Oct; 38():21-30. PubMed ID: 31132749
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of chimeric antigen receptor T cell therapy in non-human primates infected with SHIV or SIV.
Iwamoto N; Patel B; Song K; Mason R; Bolivar-Wagers S; Bergamaschi C; Pavlakis GN; Berger E; Roederer M
PLoS One; 2021; 16(3):e0248973. PubMed ID: 33752225
[TBL] [Abstract][Full Text] [Related]
12. Robust expansion of HIV CAR T cells following antigen boosting in ART-suppressed nonhuman primates.
Rust BJ; Kean LS; Colonna L; Brandenstein KE; Poole NH; Obenza W; Enstrom MR; Maldini CR; Ellis GI; Fennessey CM; Huang ML; Keele BF; Jerome KR; Riley JL; Kiem HP; Peterson CW
Blood; 2020 Oct; 136(15):1722-1734. PubMed ID: 32614969
[TBL] [Abstract][Full Text] [Related]
13. Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication.
Haran KP; Hajduczki A; Pampusch MS; Mwakalundwa G; Vargas-Inchaustegui DA; Rakasz EG; Connick E; Berger EA; Skinner PJ
Front Immunol; 2018; 9():492. PubMed ID: 29616024
[TBL] [Abstract][Full Text] [Related]
14. Current status and future development of anti-HIV chimeric antigen receptor T-cell therapy.
Mao Y; Zhao C; Zheng P; Zhang X; Xu J
Immunotherapy; 2021 Feb; 13(2):177-184. PubMed ID: 33225803
[TBL] [Abstract][Full Text] [Related]
15.
Suematsu M; Yagyu S; Nagao N; Kubota S; Shimizu Y; Tanaka M; Nakazawa Y; Imamura T
Front Immunol; 2022; 13():770132. PubMed ID: 35154098
[TBL] [Abstract][Full Text] [Related]
16. HIV-Resistant and HIV-Specific CAR-Modified CD4
Maldini CR; Gayout K; Leibman RS; Dopkin DL; Mills JP; Shan X; Glover JA; Riley JL
Mol Ther; 2020 Jul; 28(7):1585-1599. PubMed ID: 32454027
[TBL] [Abstract][Full Text] [Related]
17. Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo.
Maldini CR; Claiborne DT; Okawa K; Chen T; Dopkin DL; Shan X; Power KA; Trifonova RT; Krupp K; Phelps M; Vrbanac VD; Tanno S; Bateson T; Leslie GJ; Hoxie JA; Boutwell CL; Riley JL; Allen TM
Nat Med; 2020 Nov; 26(11):1776-1787. PubMed ID: 32868878
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Assessment of Efficacy and Safety Analysis of CAR-T Cells (ISIKOK-19) Targeting CD19-Expressing B-Cells for the First Turkish Academic Clinical Trial with Relapsed/Refractory ALL and NHL Patients.
Taştan C; Kançağı DD; Turan RD; Yurtsever B; Çakırsoy D; Abanuz S; Yılancı M; Seyis U; Özer S; Mert S; Kayhan CK; Tokat F; Açıkel Elmas M; Birdoğan S; Arbak S; Yalçın K; Sezgin A; Kızılkılıç E; Hemşinlioğlu C; İnce Ü; Ratip S; Ovalı E
Turk J Haematol; 2020 Nov; 37(4):234-247. PubMed ID: 32755128
[TBL] [Abstract][Full Text] [Related]
19. T Cell Activators Exhibit Distinct Downstream Effects on Chimeric Antigen Receptor T Cell Phenotype and Function.
Underwood S; Jin J; Shao L; Prochazkova M; Shi R; Song HW; Jin P; Shah NN; Somerville RP; Stroncek DF; Highfill SL
Immunohorizons; 2024 Jun; 8(6):404-414. PubMed ID: 38864817
[TBL] [Abstract][Full Text] [Related]
20. Chimeric antigen receptor T-cell approaches to HIV cure.
Kuhlmann AS; Peterson CW; Kiem HP
Curr Opin HIV AIDS; 2018 Sep; 13(5):446-453. PubMed ID: 29878913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
